Patents by Inventor Jenny Meylan Merlini

Jenny Meylan Merlini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201255
    Abstract: Compositions contain an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition containing the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition containing cinnamaldehyde is administered to a human. The composition containing cinnamaldehyde may be a medicament, a food product or a supplement to a food product.
    Type: Application
    Filed: February 16, 2023
    Publication date: June 29, 2023
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Adam Burbidge, Johannes Le Coutre
  • Publication number: 20220133782
    Abstract: The invention pertains to a composition containing a combination of cinnamaldehyde and zinc. The composition containing the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition containing the combination of cinnamaldehyde and zinc is administered to a human. The composition may be a medicament, a food product or a supplement.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 5, 2022
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Adam Burbidge, Johannes Le Coutre
  • Publication number: 20210353671
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.
    Type: Application
    Filed: July 29, 2021
    Publication date: November 18, 2021
    Inventors: Susana Camacho, Stephanie Michlig Gonzalez, Lucas Actis Goretta, Jenny Meylan Merlini, Johannes Le Coutre
  • Patent number: 11110120
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: September 7, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Susana Camacho, Stephanie Michlig Gonzalez, Lucas Actis Goretta, Jenny Meylan Merlini, Johannes Le Coutre
  • Publication number: 20190125793
    Abstract: Compositions contain an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition containing the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition containing cinnamaldehyde is administered to a human. The composition containing cinnamaldehyde may be a medicament, a food product or a supplement to a food product.
    Type: Application
    Filed: December 27, 2018
    Publication date: May 2, 2019
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Adam Burbidge, Johannes Le Coutre
  • Patent number: 10188678
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: January 29, 2019
    Assignee: Nestec S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Adam Burbidge, Johannes Le Coutre
  • Publication number: 20180289636
    Abstract: Compositions contain a therapeutically effective amount of p-anisaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing glycemia by improving insulin sensitivity, or improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Application
    Filed: March 5, 2018
    Publication date: October 11, 2018
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Patent number: 10092028
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight managementor promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehydeis administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 9, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Publication number: 20180125885
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.
    Type: Application
    Filed: May 24, 2016
    Publication date: May 10, 2018
    Inventors: Susana Camacho, Stephanie Michling Gonzalez, Lucas Actis Goretta, Jenny Meylan Merlini, Johannes Le Coutre
  • Patent number: 9931308
    Abstract: Compositions contain a therapeutically effective amount of p-anisaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing gylcemia by improving insulin sensitivity, or improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: April 3, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Patent number: 9867790
    Abstract: Compositions contain a therapeutically effective amount of cuminaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing gylcemia by improving insulin sensitivity or improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: January 16, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Patent number: 9801833
    Abstract: Compositions contain a therapeutically effective amount of tiglic aldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing glycemia by improving insulin sensitivity improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: October 31, 2017
    Assignee: Nestec S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Publication number: 20170224729
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.
    Type: Application
    Filed: March 17, 2015
    Publication date: August 10, 2017
    Inventors: Stephanie MICHLING GONZALEZ, Jenny MEYLAN MERLINI, Adam BURBIDGE, Johannes LE COUTRE
  • Publication number: 20170164648
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight managementor promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehydeis administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.
    Type: Application
    Filed: June 8, 2015
    Publication date: June 15, 2017
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Publication number: 20160339058
    Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement.
    Type: Application
    Filed: March 10, 2015
    Publication date: November 24, 2016
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Adam Burbridge, Johannes Le Coutre
  • Publication number: 20160175264
    Abstract: Compositions contain a therapeutically effective amount of p-anisaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing gylcemia by improving insulin sensitivity, or improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Application
    Filed: July 18, 2014
    Publication date: June 23, 2016
    Inventors: Stephanie Michlig Gonsalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Publication number: 20160151303
    Abstract: Compositions contain a therapeutically effective amount of tiglic aldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing glycemia by improving insulin sensitivity improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Application
    Filed: July 18, 2014
    Publication date: June 2, 2016
    Applicant: NESTEC S.A.
    Inventors: Stephanie Michlig Gonzalez, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre
  • Publication number: 20160151304
    Abstract: Compositions contain a therapeutically effective amount of cuminaldehyde for at least one of provoking the swallowing reflex of dysphagic patients, decreasing appetite by delaying gastric emptying, reducing body weight gain, or reducing gylcemia by improving insulin sensitivity or improving mood, memory or cognition. Methods are provided that include administering such compositions.
    Type: Application
    Filed: July 18, 2014
    Publication date: June 2, 2016
    Inventors: Stephanie Michlig Gonzales, Jenny Meylan Merlini, Susana Camacho, Johannes Le Coutre